| Sep 13, 2011
| 4:41 AM
LONDON (Reuters) - The number of people living with diabetes has soared to 366 million, and the disease kills one person every seven seconds, posing a "massive challenge" to healthcare systems worldwide, experts said on Tuesday.
The vast majority of...
| Nov 13, 2012
| 11:03 PM
LONDON (Reuters) - Diabetes is running at record levels worldwide and half the people estimated to have the disease are, as yet, undiagnosed, according to a report on Wednesday.
The number of people living with diabetes is now put at 371 million, up from...
| Feb 28, 2012
| 5:13 PM
A new study suggests that the 6% to 10% of Americans who use prescription sleep medications such as zolpidem (Ambien), temazepam (Restoril), eszopiclone (Lunesta) and zaleplon (Sonata) are more likely to develop cancer, and far more likely to die...
| Nov 29, 2011
The nation's largest-selling pharmaceutical is going generic this week. Lipitor, which is prescribed to help people reduce their cholesterol levels, is going "off-patent" Wednesday. According to a HealthDay News report, Lipitor sales were nearly $4...
| Jan 8, 2011
Although first approved to treat schizophrenia, new antipsychotic medications are increasingly being prescribed for a host of other uses, even when there is little evidence they work, U.S. researchers said on Friday.
The drugs, known as "atypical...
| Jan 18, 2010
In a quest to look younger, be healthier and feel more vital later in life, increasing numbers of men, just like Jeffry Life, are turning to testosterone and human growth hormone. Use of both hormones is controversial. Read on:
Testosterone: "Older men ....
| Jun 17, 2010
A pink pill designed to boost sex drive in women - the latest attempt by the drug industry to find a female equivalent to Viagra - fell short in two studies, federal health regulators said Wednesday.
The Food and Drug Administration is considering...
| Jul 15, 2010
Faced with conflicting and less-than-conclusive scientific evidence, a Food and Drug Administration advisory panel recommended Wednesday that the controversial diabetes drug Avandia remain on the market — but with tighter supervision and increased...
| Mar 30, 2009
Lost jobs and lost careers. Promising businesses in shambles. The college acceptance letter returned to its envelope. This is how President Obama recently described the effect of the tanking economy on ordinary Americans -- and the stresses keeping them...
| Aug 9, 2010
As the world's most-prescribed class of medications, statins indisputably qualify for the commercial distinction of "blockbuster." About 24 million Americans take the drugs — marketed under such commercial names as Pravachol, Mevacor, Lipitor, Zocor...
| Apr 13, 2009
About a year ago, patients began trooping into the office of UCLA psychiatrist Andrew Leuchter, asking whether an antipsychotic drug called Abilify "might be right for them." Few appeared to be delusional, plagued by hallucinations or suffering fearsome...